| Name | Title | Contact Details |
|---|
THE RESULTS ARE IN See how our providers and members rated Doctors HealthCare Plans. The survey results have been tallied, and we are honored that our network providers consistently rated Doctors HealthCare Plans higher than other managed care or...
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
Red Rock Power Partners is a New York, NY-based company in the Business Services sector.
Arbor Material Handling Inc is a Willow Grove, PA-based company in the Business Services sector.